Skip to main content
logo
Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
9.01
-0.30 (-3.22%)
At close: Jul 31, 2026, 4:00 PM EDT
9.17
+0.16 (1.78%)
After-hours: Jul 31, 2026, 7:34 PM EDT

Kura Oncology Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
63.7467.4853.88---
Revenue Growth
-6.25%25.24%----
Gross Profit
63.7467.4353.88---
Operating Income
-325.33-303.63-193.2-165.8-139.87-131.26
Net Income
-294.57-278.67-173.98-152.63-135.84-130.47
Earnings Per Share
-3.35-3.18-2.02-2.08-2.03-1.97
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
580.82667.24727.4423.96437.99517.96
Total Debt
24.2720.4616.5917.214.026.88
Net Cash (Debt)
556.55646.78710.8406.76423.96511.09
Net Cash Growth
-12.88%-9.01%74.75%-4.06%-17.05%-17.62%
Net Cash Per Share
6.337.388.255.556.337.70

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-77.99-64.06134.32-124.82-110.06-104.55
Capital Expenditures
-6.47-6.64-0.47-0.17-0.63-1.15
Free Cash Flow
-84.46-70.7133.85-124.99-110.69-105.7
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%99.92%100.00%---
Operating Margin
-510.39%-449.94%-358.54%---
Pretax Margin
-462.01%-412.51%-319.15%---
Profit Margin
-462.14%-412.95%-322.89%---
FCF Margin
-132.50%-104.76%248.40%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
--5.09---
PS Ratio
11.1713.5312.65---